Synergy Bioscience is a prominent Contract Research Organization (CRO) specializing in providing a wide array of scientific and technical services to the biotechnology and pharmaceutical industries. With a mission of taking discoveries to the market, the company offers services including analytical chemistry & microbiology testing, pharmaceutical development, clinical research support, and quality & compliance consulting. As a GLP/GMP FDA registered facility, DEA Licensed, CLIA-certified, ISO 17025 Certified, and NELAC-accredited CRO, Synergy Bioscience has positioned itself as a trusted ally for organizations looking to bring innovative pharmaceutical products to market. Their diverse range of services is designed to streamline processes, maintain compliance, and propel research efforts forward. Founded in 2016 and headquartered in the United States, Synergy Bioscience presents a compelling opportunity for venture capitalists seeking to invest in cutting-edge biotechnology and pharmaceutical solutions. With its proven track record and commitment to excellence, the company is poised to make a lasting impact on the industry.
There is no investment information
No recent news or press coverage available for Synergy Bioscience.